OneMedNet signs $11.5M+ agreement to supply regulatory-grade real-world imaging data for foundational AI model training
OneMedNet (Nasdaq: ONMD) announced a $11.5M+ agreement to supply regulatory-grade, de-identified DICOM imaging data from its iRWD network (1,400+ sites at April 2025, later 2,130+) for foundation AI model training. The buyer is not named. OneMedNet does the de-identification and curation up front, takes a one-off fee, and does not share in the trained model's downstream value.
Where the rake sits
OneMedNet is paid $11.5M+ for curation, de-identification and regulatory-grade formatting — work it performs and prices. It holds no claim on what the corpus becomes: the buyer's training creates the durable asset and keeps it permanently. Whether $11.5M is the right price for that input is not determinable from the disclosed terms, and that pricing question, not a recoverable share, is what the deal turns on.
What happened
- OneMedNet (Nasdaq: ONMD) announced an agreement worth $11.5M+ to supply regulatory-grade real-world imaging data for foundational AI model training.
- The buyer is not publicly named in the announcement.
- OneMedNet's iRWD platform sources de-identified imaging and clinical records from a federated network of 1,400+ provider sites (April 2025 disclosure), later expanded to 2,130+ sites.
- Disclosed corpus scale at announcement: 121M clinical exams from 31M unique patients; subsequent disclosures cite 90M patient journeys and 270M studies by August 2026.
- The stated buyer purpose is foundational AI model training — a downstream artefact whose commercial value is not shared back to OneMedNet under the announced fee.
- OneMedNet's contribution includes de-identification, cohort-spec matching and provenance-tracing curation on top of raw DICOM archives.
Who is involved
US regulatory-grade imaging real-world-data provider; its iRWD platform curates de-identified medical imaging and clinical records federated from 1,400+ (later 2,130+) healthcare provider sites for life-science and AI buyers.
Nasdaq: ONMD; iRWD network of 121M clinical exams from 31M unique patients across 1,400+ sites as of April 2025; expanded to 2,130 sites and 90M patient journeys / 270M studies by Aug 2026.
The reading
OneMedNet does the enrichment: it pulls raw DICOM archives from its 1,400+ site network, de-identifies, curates against sponsor cohort specifications and delivers structured datasets. Owner-enriched, using a proprietary matching pipeline and clinical curation team.
For a foundation-model developer, the value is not just images but images matched to cohort specifications with associated clinical context, at regulatory-decision quality - the kind of curated, provenance-traceable corpus that an untamed hospital dump cannot supply.
What crosses is a licensed, de-identified imaging dataset delivered to the buyer's environment. What stays inside OneMedNet is the underlying federated provider relationships, PHI, and the curation stack itself.
Not determinable. The counterparty is not named, and $11.5M+ against a foundational-model training run whose downstream value is unknown does not settle whether the fee was well-priced against what the buyer extracts.
Why it matters
A regulatory-grade, cohort-matched imaging corpus is exactly the substrate a foundation-model developer cannot assemble by scraping — which is why OneMedNet gets paid — but a one-off $11.5M fee against a training run whose output may power years of downstream product is the classic shape of under-capture. Is this really under-capture, or as a defensible bet given OneMedNet's stage and the buyer's willingness to sign at that number?
The argument this deal tests: The identifier on loan
Related deals
- Google wins $10M bankruptcy auction for Spirit Airlines' enterprise data and code to train AI models2026-08-14
- Chegg pivots to licensing decade of proprietary STEM academic content and expert network to AI labs2026-05-13
- CuriosityStream Q2 2026 press release discloses $14.1M licensing revenue driven by AI training partnerships2026-08-12
- Tempus expands multi-year Merck collaboration giving Merck access to de-identified multimodal data and Lens platform2026-03-03
Sources
- globenewswire.com — primary
- nasdaq.com — party background
- sec.gov — party background
Announced 2026-07-28 · Added to the register 2026-08-01